Controller medications, also known as daily maintenance medications, are a critical tool for managing asthma — reducing daily ...

Scientists at deCODE genetics and collaborators have published a study in the Journal of Allergy and Clinical Immunology ...

Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca (AZ) and development partner Avillion, has been approved by the US Food and Drug Administration (FDA). A first-in-class ...

There is a need to develop new anti-inflammatory therapies for this disease. This article critically reviews clinical trial data of novel anti-inflammatory drugs in asthma, encompassing specific ...

Researchers at National Jewish Health and colleagues have identified a mechanism involved in the formation of mucus plugs in ...

Upstream Bio garners analyst optimism for its lead drug verekitug, which could disrupt the $7.5 billion asthma biologics ...

At the recent American College of Allergy, Asthma & Immunology (ACAAI) annual meeting, experts discussed the evolving concept ...

Over 40 companies are working on more than 50 therapies for severe asthma. The severe asthma market is growing due to a ...

Asthma is associated with memory problems in children, a new study has found. Further, the early onset of asthma might worsen ...

Asthma in early childhood could be linked to memory deficits, according to a new UC Davis study ... Research with rodents has ...